Toussirot E, Vauchy C, Binda D, Michel F. Drug Des Devel Ther. 2016;10:2087–2094.
On page 2089, a column heading in was incorrectly presented. The last column heading was presented as “Golimumab 60 mg”, whereas this should have been presented as “Golimumab 100 mg” as shown below:
Table 1 Proportion of ASAS20 responders in the GO-RAISE and GO-AHEAD studies